Key result
An infant presented with hypertrophic cardiomyopathy and hypotonia on the first day of life, with muscle biopsy confirming nemaline myopathy at 3 weeks of age, precluding heart transplantation.
Case Report (n=1)
This case highlights that nemaline myopathy can present with hypertrophic cardiomyopathy as early as the first day of life, which may preclude heart transplantation.
Answers are grounded in this paper and cite their sources.
Neonates with HCM and hypotonia may warrant early muscle biopsy; hypothesis-generating for nemaline myopathy precluding transplantation.
Nemaline myopathy is a congenital nonprogressive skeletal muscle disorder with a characteristic rod body formation in the skeletal muscle fibers. Cardiac involvement in nemaline myopathy is rare, although both dilated and hypertrophic cardiomyopathy have been reported. We describe an infant diagnosed with hypertrophic cardiomyopathy and hypotonia on the first day of life. Muscle biopsy confirmed nemaline myopathy at 3 weeks of age. The diagnosis of nemaline myopathy precluded consideration of heart transplantation, thus shifting the focus to comfort care. This is the earliest presentation of hypertrophic cardiomyopathy reported in the literature in the setting of nemaline myopathy. The approach to determining an etiology for hypertrophic cardiomyopathy in an infant is reviewed.
No takes yet. Share an insight, caveat, or question.
Mir et al. (2011) conducted a case report in Hypertrophic cardiomyopathy and nemaline myopathy (n=1). Nemaline myopathy was evaluated. An infant presented with hypertrophic cardiomyopathy and hypotonia on the first day of life, with muscle biopsy confirming nemaline myopathy at 3 weeks of age, precluding heart transplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: